1-3 of 3
Anita Schmitt
Close
Sort by
Journal Articles

Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy

Huixiu Han, Lei Wang, Yuntian Ding, Brigitte Neuber, Angela Hückelhoven-Krauss, Min Lin, Hao Yao, Qian Chen, Tim Sauer, Maria-Luisa Schubert, Zhiqiang Guo, Carsten Müller-Tidow, Michael Schmitt, Anita Schmitt
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2675–2690.
https://doi.org/10.1182/bloodadvances.2023012463
Published: 2024
Includes: Supplemental data
Journal Articles

Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment

Clinical Trials & Observations
Florian Schoeberl, Steffen Tiedt, Anita Schmitt, Viktoria Blumenberg, Philipp Karschnia, Vanessa Granja Burbano, Veit L. Bücklein, Kai Rejeski, Christian Schmidt, Galina Busch, Michael von Bergwelt-Baildon, Jörg-Christian Tonn, Michael Schmitt, Marion Subklewe, Louisa von Baumgarten
Journal: Blood Advances
Blood Adv (2022) 6 (10): 3022–3026.
https://doi.org/10.1182/bloodadvances.2021006144
Published: 2022
Journal Articles

CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma: an intent-to-treat comparison

Clinical Trials & Observations
Peter Dreger, Sascha Dietrich, Maria-Luisa Schubert, Lorenz Selberg, Andrea Bondong, Mandy Wegner, Peter Stadtherr, Christoph Kimmich, Florentina Kosely, Anita Schmitt, Petra Pavel, Nora Liebers, Thomas Luft, Ute Hegenbart, Aleksandar Radujkovic, Anthony Dick Ho, Carsten Müller-Tidow, Michael Schmitt
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6157–6168.
https://doi.org/10.1182/bloodadvances.2020003036
Published: 2020
Includes: Supplemental data